Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial
Saved in:
| Title: | Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial |
|---|---|
| Authors: | Bouvier, Anne1 (AUTHOR), Hamel, Jean‐François2 (AUTHOR), Delaunay, Jacques3 (AUTHOR), Delabesse, Eric4 (AUTHOR), Dumas, Pierre‐Yves5 (AUTHOR), Ledoux, Marie‐Pierre6 (AUTHOR), Peterlin, Pierre3 (AUTHOR), Luquet, Isabelle4 (AUTHOR), Roth Guepin, Gabrielle7 (AUTHOR), Bulabois, Claude Eric8 (AUTHOR), Gallego Hernanz, Maria Pilar9 (AUTHOR), Guillerm, Gaëlle10 (AUTHOR), Guieze, Romain11 (AUTHOR), Hicheri, Yosr12 (AUTHOR), Simand, Célestine13 (AUTHOR), Himberlin, Chantal14 (AUTHOR), Hunault‐Berger, Mathilde15 (AUTHOR), Bernard, Marc16 (AUTHOR), Jourdan, Eric17 (AUTHOR), Caillot, Denis18 (AUTHOR) |
| Source: | European Journal of Haematology. Jul2021, Vol. 107 Issue 1, p111-121. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
